Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pneumonitis
ADR ID BADD_A03482
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.01      Lower respiratory tract inflammatory and immunologic conditions
22.01.01.006      Pneumonitis
Description A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma. [CTCAE] Infection of the lung often accompanied by inflammation. | Inflammation of any part, segment or lobe, of the lung parenchyma. [MeSH]
MedDRA Code 10035742
MeSH ID D011014
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Pneumonitis | Pneumonitis NOS | Pulmonitis | Lung inflammation | Chronic pneumonitis | Obstructive pneumonitis | Noninfectious pneumonitis | Pneumonia | Pneumonias | Lobar Pneumonia | Lobar Pneumonias | Pneumonias, Lobar | Pneumonia, Lobar | Experimental Lung Inflammation | Experimental Lung Inflammations | Inflammation, Experimental Lung | Lung Inflammation, Experimental | Lung Inflammations, Experimental | Pneumonitides | Pulmonary Inflammation | Inflammation, Pulmonary | Inflammations, Pulmonary | Pulmonary Inflammations | Lung Inflammation | Inflammation, Lung | Inflammations, Lung | Lung Inflammations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02596Sotorasib0.001690%
BADD_D02599Tepotinib0.000246%
BADD_D02609Zanubrutinib0.000112%
The 6th Page    First    Pre   6    Total 6 Pages